ATS 2019 Virtual Final Program

909 Oral Administration of 8-Cyclopentyl-1,3-Dipropylxanthine (DPCPX) After C2 Spinal Cord Hemisection Improves Sleep Disordered Breathing/ P. Farshi, W. Mansour, F. Liu, G. Mao, H. Goshgarian, A. Sankari, Detroit, MI, p.A2594 910 Effects of Solriamfetol in a Long-Term Phase 3 Trial: Analysis of Adherence to Primary Obstructive Sleep Apnea (OSA) Therapy/ P. Schweitzer, K.P. Strohl, G. Mayer, R. Rosenberg, P. Chandler, M. Baladi, L. Lee, A. Malhotra, Chesterfield, MO, p.A2595 911 Acetazolamide for Sleep Disordered Breathing: A Systematic Review and Meta-Analysis of Effects and Side Effects/ C. Schmickl, R.L. Owens, A. Malhotra, San Diego, CA, p.A2596 912 Evolution of Sleep-Disordered Breathing After Discharge in Patients with Acute Decompensated Heart Failure/ R.N. Aurora, A. Blase, A. Benjafield, C.M. O’Connor, N.M. Punjabi, New Brunswick, NJ, p.A2597 913 Low Arousal Threshold Correlates with Reduced Continuous Positive Airway Pressure Use in Non-Obese Individuals with Obstructive Sleep Apnea and Stroke/ A. Zinchuk, H.K. Yaggi, J. Concato, S. Jeon, D. Bravata, D.A. Wellman, S.A. Sands, New Haven, CT, p.A2598 914 Changes in Quantitative Pathophysiological Traits Causing Obstructive Sleep Apnea on Acute CPAP Withdrawal/ A. Parekh, S.A. Sands, A.W. Varga, D.M. Rapoport, I.A. Ayappa, New York, NY, p.A2599 915 The Impact of Age, Gender and OSA Severity on 1 Year PAP Adherence: Results from a Big Data Analysis of OSA Patients/ J.P. Armitstead, A. Malhotra, A.V. Benjafield, H. Shi, P.A. Cistulli, J.-L. Pepin, C. Nunez, H. Woehrle, Sydney, Australia, p.A2600 916 Easy-to-Build and Affordable CPAP Device for Low-Income Countries: Open-Source Hardware Description and Bench Test Performance/ R. Farre, G. Solana, D. Gozal, J.M. Montserrat, D. Navajas, Barcelona, Spain, p.A2601 917 Continuous Positive Airway Pressure (CPAP) Treatment Reduces Mortality at the Population Level in Catalonia/ S. Bertran, J. de Batlle, C. Turino, J. Escarrabill, A. García-Altés, E. Martinez Carbonell, M. Sanchez-de-la-Torre, F. Barbe, Lleida, Spain, p.A2602 918 Sleep Study-Guided Multidisciplinary Therapy for Acute Coronary Syndrome: A Randomized Clinical Trial/ A.P. Chua, C.Y. Koo, W. Kristanto, H.T. Koh, T. Siang Joo, S.A. Rahman, M.B.A. Gani, P.C. Chong, A. Aung, T.O. Han, S.P. Chan, A. Low, T.C. Yeo, M. Chan, P. Kojodjojo, A.M. Richards, C.H. Lee, Singapore, Singapore, p.A2603 919 Effective Treatment of Obstructive Sleep Apnea with CPAP Reduces Major Adverse Cerebrocardiovascular Outcomes: A Systematic Review and Meta-Analysis of Per-Protocol Use of CPAP in Randomized Controlled Trials/ S. Javaheri, M.A. Martinez-Garcia, F. Campos-Rodriguez, A. Muriel, Y. Peker, Cincinnati, OH, p.A7350 920 OSA Phenotypic Traits in Morbid Obese Patients with Isolated Sleep Hypoventilation/ E. Perger, L. Taranto Montemurro, S.A. Sands, J. Aron-Wisnewsky, I. Arnulf, J.-M. Oppert, D.A. Wellman, T. Similowski, S. Redolfi, Milan, Italy, p.A7351 CLINICAL RAPID: RAPID ABSTRACT POSTER DISCUSSION SESSION A110 NOVEL IMAGING FOR LUNG CANCER: A PICTURE IS WORTH A THOUSAND WORDS 2:15 p.m. - 4:15 p.m. KBHCCD Arena (Level 2) Abstract Summaries 2:15-2:45 Viewing/Discussion 2:45-4:15 Chairing: F. Maldonado, MD, Nashville, TN N.T. Tanner, MD, MSCR, Charleston, SC S. Shojaee, MD, MPH, Richmond, VA 401 Imaging Biomarkers for Improved Lung Cancer Prediction Through Reclassification of Indeterminate Pulmonary Nodules/ D. Lakhani, A. Balar, S. Antic, S.-C. Chen, J. Qian, U. Barad, B. Landman, R. Nguyen, T. Atwater, C. Shah, A. Kaizer, P. Williams, A. Baron, G. Smith, D. Wilson, J. Leader, H. Chen, P.P. Massion, Nashville, TN, p.A2604 402 Multi-Center Independent Validation of AI Risk Stratification for Indeterminate Pulmonary Nodules from CT Images/ F. Gleeson, S. Ather, A. Talwar, J. Gustafson, W. Hickes, M. Clark, V. Ashford-Turner, E. Reason, P. Holland, T. Kadir, J. Declerck, L. Pickup, C. Arteta, P. Novotny, A. Sterba, M. Callister, D. Baldwin, Oxford, United Kingdom, p.A2605 403 Repeated Measures of Risk Based on Radiomics Features of Indeterminate Pulmonary Nodules for the Early Discrimination Between Benign and Malignant Disease/ A. Balar, D. Lakhani, S. Antic, J. Qian, R. Nguyen, B. Landman, H. Chen, S.-C. Chen, K.L. Sandler, C. Shah, G. Smith, P.P. Massion, Nashville, TN, p.A2606 404 The Predictive Value of Transthoracic Shear-Wave Ultrasound Elastography in Differentiating Benign from Malignant Lung Tumors/ Y.-W. Kuo, Y.-L. Chen, J.-Y. Shih, H.-C. Wang, H.-D. Wu, Taipei City, Taiwan, p.A2607 405 Artificial Intelligence vs. LungRADs for Lung Nodule Diagnosis in an Asian Population/ D. Yang, C. Bai, N. Wang, J. Hu, S. Lu, W. Shi, J. Wang, W. Li, H. Li, D. Gao, X. Zhong, C.A. Powell, New York, NY, p.A2608 406 Feasibility of a Prototype Carbon Nanotube Enabled Stationary Digital Chest Tomosynthesis System (s-DCT) for Identification of Pulmonary Nodules Seen on Chest Computed Tomography (CT)/ A.C. Burks, J. Akulian, A.R. Belanger, M.P. Rivera, J. Lu, O. Zhou, Y. Lee, Chapel Hill, NC, p.A2609 407 Concordance Between Artificial Intelligence and Multidisciplinary Tumor Board for Lung Cancer/ M. Kim, H.-Y. Park, B.-G. Kho, C.-K. Park, I.-J. Oh, Y.-C. Kim, Gwangju, Korea, Republic of, p.A2610 408 Identifying an Infrared Spectral Biomarker of Lung Cancer Risk/ S. Antoniou, K.H.C. Gowers, S.M. Janes, London, United Kingdom, p.A2611 ATS 2019 • Dallas, TX SUNDAY • MAY 19 117 SUNDAY AFTERNOON